---

Bedaquiline –A new drug against multidrug-resistant tuberculosis

Full Text PDF

---

Short Communication

Author Details : Sankalp Yadav, Gautam Rawal

Volume : 5, Issue : 2, Year : 2018

Article Page : 106-107

https://doi.org/10.18231/2394-2797.2018.0017

Suggest article by email

Get Permission

Abstract

The infectious diseases have taken a toll on the rapidly multiplying population of the developing countries. The top three killers being HIV AIDS, TB and malaria. The total number of deaths due to TB is really a cause of concern since a well laid national program is running in most of these countries. However, even in the presence of clear guidelines to treat TB, there has always been a gradual rise in the new cases with few exceptions in some of these resource-constrained countries. The issue becomes graver when the problem of drug-resistant TB also comes into the picture. In the present article, the authors highlight the introduction of the new drug i.e., Bedaquiline in India to counter the problem of multidrug-resistant TB.

Keywords: Bedaquiline, Drug; Drug-resistant, TB; Tuberculosis

How to cite : Yadav S, Rawal G, Bedaquiline –A new drug against multidrug-resistant tuberculosis. Int J Pharm Chem Anal 2018;5(2):106-107

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.